Leonteq Securities AG

Leonteq Securities AG is the main operating and issuing entity of Leonteq AG, a Zurich-based specialist in structured investment products and insurance-linked solutions. Established in Switzerland and listed on SIX Swiss Exchange via its parent company, Leonteq has built a capital markets and technology platform that designs, structures, and distributes tailor-made investment products for banks, insurers, and other institutional partners. Leonteq Securities AG serves as the issuer and trading hub for these instruments, handling origination, risk management, and secondary-market activity. While it is not a traditional asset manager in the sense of running benchmark-relative equity portfolios, it qualifies as an institutional investment manager for U.S. regulatory purposes and files Form 13F with the U.S. Securities and Exchange Commission under CIK #0001535950. The firm’s 13F reports capture U.S.-listed long equity and certain equity-linked positions that arise predominantly from hedging and risk transfer around the structured products it manufactures. These filings therefore provide a window into the underlying reference assets and hedging instruments embedded in its product platform, rather than a discretionary “house view” equity portfolio. Leonteq’s business model is primarily B2B: it partners with private banks, retail banks, and insurance companies that distribute structured products and annuity solutions to their own client bases. Leonteq Securities AG is regulated by FINMA in Switzerland as a securities dealer and is subject to local capital, conduct, and risk management standards. Its SEC reporting role is a complement to this framework, focused specifically on disclosing U.S. equity exposures that meet 13F criteria. As 13F History accumulates, SEC filings under CIK #0001535950 allow allocators and counterparties to study how the U.S.-listed portion of Leonteq’s hedging and issuance book has evolved across market regimes, even though this is only one slice of the broader global derivatives and structured products platform.

Leonteq Securities AG does not operate a classic active equity strategy with a mandate such as “U.S. large-cap value” or “global growth.” Instead, its portfolio of U.S.-listed securities disclosed on Form 13F is largely a by-product of its role as a structured products and derivatives manufacturer. The firm structures products linked to a wide array of underlyings—single stocks, equity indices, baskets, ETFs, rates, commodities, and more. To manage the risk of these products, Leonteq Securities AG runs a dynamic hedging and market-making program. That program often involves holding positions in U.S.-listed stocks, ADRs, and ETFs to offset the sensitivities (delta, gamma, vega, etc.) of products sold to clients. Consequently, the 13F book is driven primarily by: - The mix of underlying reference assets embedded in structured products sold to end-investors. - The hedging strategy for those products, including the use of cash equities and ETFs as hedging instruments. - Inventory and facilitation needs as Leonteq quotes and manages products in the secondary market. In this context, the observed 13F Portfolio Composition—the list of U.S. equities, ADRs, and ETFs and their relative weights—is a reflection of risk-transfer and hedging flows rather than top-down sector or stock selection. Sector exposures and position sizes may shift rapidly as client demand and structured-product issuance patterns change. Strategically, Leonteq’s style is best characterized as quantitative and derivatives-driven: positions are established, resized, or closed primarily in response to changes in the risk profile of outstanding products, movements in volatility, and the firm’s risk limits, rather than through discretionary stock picking based on fundamental research. For allocators or counterparties using a Portfolio Simulator or Backtesting Service, it is critical to recognize that a simulated equity-only replica of Leonteq Securities AG’s 13F disclosures is a representation of its net long U.S. equity hedging book, not of a traditional active investment strategy. While such replications can be informative about embedded factor exposures or concentration, they do not capture the full payoff structure of the structured products themselves.

Leonteq Securities AG occupies a distinct position among 13F filers. Its reported U.S. equity holdings are a function of a structured products and derivatives-hedging business rather than a conventional asset management mandate. The holdings under CIK #0001535950 thus provide an indirect view into the composition of underlyings and hedges supporting Leonteq’s structured product platform. Over time, the firm’s 13F Portfolio Composition can be used to track how U.S. equity and ETF exposures evolve as client demand, product design, and volatility regimes change. By applying a Portfolio Simulator to this history, users can reconstruct a 13F-based Historical Track Record of a notional long-equity proxy, quantifying its capital trajectory, sector shifts, and concentration dynamics. Layering on standard risk analytics—such as a rolling Volatility Profile and summary Sharpe Ratio for the replicated series—helps contextualize how the disclosed sleeve has behaved through different market cycles. These metrics are informative when interpreted for what they are: a lens on the net long U.S. equity footprint associated with Leonteq’s hedging operations, not a holistic measure of the firm’s derivative or counterparty risk. For allocators, trading counterparties, or due-diligence teams, the analytical challenge is to reconcile this 13F-based view with qualitative understanding of Leonteq’s structured-products engine: how product design, hedging philosophy, and risk limits translate into evolving equity exposures, and how those exposures might respond under sharply different volatility and correlation regimes going forward.

The economic risk profile of Leonteq Securities AG is dominated by its role as a structured product issuer and derivatives dealer, with a focus on managing complex option payoffs and associated market, credit, and operational risks. The 13F disclosures show only the long U.S. equity and equity-linked instruments used within this broader risk framework. When viewed through a 13F lens, several features of the risk profile stand out: - Positions are often widely diversified across sectors and instruments, reflecting the breadth of client demand for products on different underlyings. - Exposures can change quickly as options decay, barriers are touched, or products are early-redeemed, leading to a high level of trading and repositioning. - Individual line items in the 13F can be large in notional terms, but these may be partially or fully offset by derivatives or positions in other markets that are not visible in 13F data. If one constructs a purely long-only, 13F-based replication of Leonteq Securities AG’s disclosed holdings, the resulting time series will show a certain realized Volatility Profile and episodic drawdowns that reflect net long equity exposure at the reporting dates. From this, standard statistics such as Sharpe Ratio and drawdown measures can be computed. However, these outputs describe the behavior of a simplified proxy for the hedging book, not the firm’s true residual risk after taking into account options, delta-hedging, and positions in non-U.S. markets or other asset classes. Because Leonteq actively manages its hedge ratios, the long-equity sleeve may at times appear to carry meaningful directional beta to equity markets and at other times may look more neutral, depending on the mix and moneyness of outstanding products. Large market shocks—particularly moves in volatility and correlation—can induce rapid changes in the composition and size of the hedging book, which would show up in 13F as shifts in exposure and, retrospectively, as periods of heightened or compressed Max Drawdown Depth for a long-only replication. For risk assessment, 13F-based analytics are therefore best used to understand the structure of disclosed U.S. equity exposures—concentration by issuer, sector clustering, and changes over time—rather than to infer Leonteq’s aggregate risk position. True economic risk depends on the full derivatives stack, collateral and funding arrangements, and risk-transfer mechanisms that lie outside the scope of Form 13F.